Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
2.600
+0.030 (1.17%)
At close: Dec 20, 2024, 4:00 PM
2.570
-0.030 (-1.15%)
After-hours: Dec 20, 2024, 4:40 PM EST
Citius Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | 2018 - 2014 |
| Cash & Equivalents | 17.91 | 26.48 | 41.71 | 70.07 | 13.86 | 7.89 | Upgrade
|
| Cash & Short-Term Investments | 17.91 | 26.48 | 41.71 | 70.07 | 13.86 | 7.89 | Upgrade
|
| Cash Growth | -46.18% | -36.51% | -40.47% | 405.59% | 75.58% | -14.05% | Upgrade
|
| Prepaid Expenses | 10.09 | 7.89 | 2.85 | 2.74 | 0.12 | 0.05 | Upgrade
|
| Total Current Assets | 28.01 | 34.37 | 44.56 | 72.81 | 13.98 | 7.94 | Upgrade
|
| Property, Plant & Equipment | 0.3 | 0.46 | 0.65 | 0.83 | 0.99 | 0 | Upgrade
|
| Goodwill | 9.35 | 9.35 | 9.35 | 9.35 | 9.35 | 9.35 | Upgrade
|
| Other Intangible Assets | 59.4 | 59.4 | 59.4 | 59.4 | 19.4 | 19.4 | Upgrade
|
| Other Long-Term Assets | 0.04 | 0.04 | 0.04 | 0.04 | 0.06 | 0.06 | Upgrade
|
| Total Assets | 97.09 | 103.61 | 114 | 142.43 | 43.77 | 36.75 | Upgrade
|
| Accounts Payable | 1.66 | 2.93 | 1.17 | 1.28 | 1.86 | 2.71 | Upgrade
|
| Accrued Expenses | 2.25 | 2.63 | 3.17 | 2.53 | 1.91 | 1.72 | Upgrade
|
| Short-Term Debt | - | - | - | - | 0.17 | 0.17 | Upgrade
|
| Current Portion of Leases | 0.24 | 0.22 | 0.2 | 0.18 | 0.16 | - | Upgrade
|
| Total Current Liabilities | 4.15 | 5.78 | 4.53 | 3.98 | 4.1 | 4.61 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.16 | - | Upgrade
|
| Long-Term Leases | 0.08 | 0.26 | 0.48 | 0.68 | 0.86 | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 6.57 | 6.14 | 5.56 | 4.99 | 4.99 | 4.99 | Upgrade
|
| Total Liabilities | 10.81 | 12.18 | 10.57 | 9.65 | 10.1 | 9.59 | Upgrade
|
| Common Stock | 0.18 | 0.16 | 0.15 | 0.15 | 0.06 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 276.08 | 252.9 | 232.37 | 228.08 | 104.21 | 80.17 | Upgrade
|
| Retained Earnings | -190.58 | -162.23 | -129.69 | -96.05 | -70.59 | -53.05 | Upgrade
|
| Total Common Equity | 85.68 | 90.83 | 102.83 | 132.18 | 33.67 | 27.15 | Upgrade
|
| Minority Interest | 0.6 | 0.6 | 0.6 | 0.6 | - | - | Upgrade
|
| Shareholders' Equity | 86.28 | 91.43 | 103.43 | 132.78 | 33.67 | 27.15 | Upgrade
|
| Total Liabilities & Equity | 97.09 | 103.61 | 114 | 142.43 | 43.77 | 36.75 | Upgrade
|
| Total Debt | 0.32 | 0.48 | 0.68 | 0.86 | 1.35 | 0.17 | Upgrade
|
| Net Cash (Debt) | 17.59 | 26 | 41.03 | 69.22 | 12.51 | 7.72 | Upgrade
|
| Net Cash Growth | -46.28% | -36.64% | -40.72% | 453.40% | 62.00% | -14.32% | Upgrade
|
| Net Cash Per Share | 2.70 | 4.30 | 7.02 | 15.93 | 7.98 | 9.57 | Upgrade
|
| Filing Date Shares Outstanding | 7.23 | 6.36 | 5.85 | 5.84 | 2.22 | 1.16 | Upgrade
|
| Total Common Shares Outstanding | 7.23 | 6.35 | 5.85 | 5.84 | 2.22 | 1.16 | Upgrade
|
| Working Capital | 23.85 | 28.59 | 40.03 | 68.83 | 9.88 | 3.33 | Upgrade
|
| Book Value Per Share | 11.85 | 14.29 | 17.58 | 22.64 | 15.15 | 23.46 | Upgrade
|
| Tangible Book Value | 16.94 | 22.08 | 34.08 | 63.44 | 4.92 | -1.59 | Upgrade
|
| Tangible Book Value Per Share | 2.34 | 3.48 | 5.83 | 10.86 | 2.21 | -1.38 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.